Vista Pharmaceuticals Ltd

524711·NSE·
₹0.00▲ +0.00 (+0.00%)
Market Cap43.18 Cr
PE Ratio—
Volume—
Day High - Low—
52W High-Low11.45 - 5.71

Vista Pharmaceuticals Ltd (524711): company summary

Vista Pharmaceuticals Ltd (524711) is a micro-cap Healthcare company valued at ₹43 crore operating in Pharmaceuticals on the NSE and BSE.

Vista Pharmaceuticals Ltd (524711) is a micro-cap Healthcare company valued at ₹43 crore operating in Pharmaceuticals on the NSE and BSE.

Financial performance
Revenue has been growing strongly at 75.4% a year over three years. Return on equity is -29.5%.
Valuation multiples
A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 1.19 times book value.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
2.9/10
Poor
Fair Value
Sign in to see
ROE
-29.50%
Weak
P/E
—
Debt / Equity
0.28
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

52W₹5.71
₹11.45
DocStoX take

Supported by growth (7.5) and valuation (6.0), but held back by quality (0.0). Growth looks strong at 7.5, but that is offset by quality at 0.0. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.

DocStoX score

Low confidence
2.9
/10
Poor
Quality
Weak
ROE -29.5%
Valuation
Fair
P/B 1.2× on assets (no earnings to value)
Growth
Strong
Revenue +40.1% 5Y CAGR
Risk
Moderate
D/E 0.28
Momentum
No data
No technical indicators

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹43 Cr
52W High / Low
₹11 / ₹6
Dividend Yield
0.00%
Promoter Holding
21.19%
EPS (TTM)
₹-1.26
Book Value
₹5.92

Key highlights

  • Revenue compounding 40% a year
  • Loss-making in some of the last 5 years
  • Quality is weak (0.0/10)
1 Positive3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Vista Pharmaceuticals Ltd’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Vista Pharmaceuticals Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDMAX HEALTHCARE INS LTDAUROBINDO PHARMA LTDDR. REDDY S LABORATORIESLUPIN LIMITEDMANKIND PHARMA LIMITED

Compare Vista Pharmaceuticals Ltd with peers

Vista Pharmaceuticals Ltd vs SUN PHARMACEUTICAL IND LVista Pharmaceuticals Ltd vs DIVI S LABORATORIES LTDVista Pharmaceuticals Ltd vs TORRENT PHARMACEUTICALS LVista Pharmaceuticals Ltd vs APOLLO HOSPITALS ENTER. LVista Pharmaceuticals Ltd vs ZYDUS LIFESCIENCES LTDVista Pharmaceuticals Ltd vs CIPLA LTD

Related tools & concepts

Value Vista Pharmaceuticals Ltd with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing